465 related articles for article (PubMed ID: 14652883)
1. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
2. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
3. The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy.
Coupes BM; Kon SP; Brenchley PE; Short CD; Mallick NP
Nephrol Dial Transplant; 1993; 8(5):397-401. PubMed ID: 8393542
[TBL] [Abstract][Full Text] [Related]
4. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
5. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of C3dg and C5b-9 in human membranous nephropathy.
Coupes B; Brenchley PE; Short CD; Mallick NP
Nephrol Dial Transplant; 1992; 7 Suppl 1():32-4. PubMed ID: 1337180
[No Abstract] [Full Text] [Related]
7. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
9. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis.
Honkanen E; Teppo AM; Meri S; Lehto T; Grönhagen-Riska C
Nephrol Dial Transplant; 1994; 9(11):1553-9. PubMed ID: 7870341
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in glomerulonephritis.
Solling J; Olsen S
Clin Nephrol; 1981 Aug; 16(2):63-74. PubMed ID: 7021032
[TBL] [Abstract][Full Text] [Related]
12. Food antigens, IgA-immune complexes and IgA mesangial nephropathy.
Fornasieri A; Sinico RA; Maldifassi P; Paterna L; Benuzzi S; Colasanti G; D'Amico G
Nephrol Dial Transplant; 1988; 3(6):738-43. PubMed ID: 3147415
[TBL] [Abstract][Full Text] [Related]
13. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis.
Lehto T; Honkanen E; Teppo AM; Meri S
Kidney Int; 1995 May; 47(5):1403-11. PubMed ID: 7543624
[TBL] [Abstract][Full Text] [Related]
15. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
[TBL] [Abstract][Full Text] [Related]
16. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
[TBL] [Abstract][Full Text] [Related]
17. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
[TBL] [Abstract][Full Text] [Related]
18. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
19. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
Kusunoki Y
Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
[TBL] [Abstract][Full Text] [Related]
20. Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy.
Doi T; Kanatsu K; Sekita K; Yoshida H; Nagai H; Hamashima Y
J Immunol Methods; 1984 Apr; 69(1):95-104. PubMed ID: 6371143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
